UBS Maintains Buy on Humana, Lowers Price Target to $560
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Kevin Caliendo has maintained a 'Buy' rating on Humana (NYSE:HUM) but lowered the price target from $620 to $560.
July 13, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS has maintained a 'Buy' rating on Humana but lowered the price target from $620 to $560. This could potentially impact the stock's performance.
While the 'Buy' rating is maintained, the lowering of the price target could indicate a potential decrease in the expected future value of the stock. This could lead to mixed reactions in the market, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100